These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 317941)

  • 1. [Pharmacology of a beta-adrenolytic agent, carteolol].
    Imperatore A; Vacca C; Giordano L; Lampa E; Perna D; Rossi F; Montanino C; Marmo E
    Boll Chim Farm; 1979 Oct; 118(10):617-45. PubMed ID: 317941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacodynamics of carteolol].
    Odenthal KP
    Arzneimittelforschung; 1983; 33(2a):281-5. PubMed ID: 6132609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselectivity in beta-adrenomimetic and beta-adrenolytic actions of carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic action in guinea-pig taenia caecum.
    Takayanagi I; Hagiwara H; Koike K
    Gen Pharmacol; 1990; 21(3):309-12. PubMed ID: 1971247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human pharmacology of carteolol].
    Lorenz D
    Arzneimittelforschung; 1983; 33(2a):296-304. PubMed ID: 6682321
    [No Abstract]   [Full Text] [Related]  

  • 5. A possible mechanism of action of a beta-adrenergic partial agonist (carteolol) in guinea pig taenia caecum.
    Takayanagi I; Koike K
    J Pharmacobiodyn; 1983 Jan; 6(1):56-9. PubMed ID: 6304281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
    Saborowski F; Dundalek E; Griebenow R; Sy M
    Arzneimittelforschung; 1983; 33(2a):310-2. PubMed ID: 6682322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelium-dependent effects of carteolol.
    Janczewski P; Boulanger C; Iqbal A; Vanhoutte PM
    J Pharmacol Exp Ther; 1988 Nov; 247(2):590-5. PubMed ID: 2903235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inotropic and chronotropic responses of isolated canine atrium to 5-(3-tert.-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol).
    Chiba S
    Arzneimittelforschung; 1979; 29(6):895-7. PubMed ID: 582780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacology of amitriptylinoxide.
    Leuschner F; Neumann W; Doppelfeld IS; Erdös A; Fontaine R; Gabbar HA; Graf E
    Arzneimittelforschung; 1978; 28(10b):1883-93. PubMed ID: 38803
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonistic effects of guanabenz, carteolol, and muzolimine on hypertensive responses in the anesthetized dog.
    Marmo E; Lampa E; Chieppa S; Bile G; Romano AR; Vacca C; Spadaro R
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):25-33. PubMed ID: 6505388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local anesthetic effect and subjective tolerance of 2% carteolol and 0.6% metipranolol on healthy eyes].
    Höh H
    Klin Monbl Augenheilkd; 1989 Apr; 194(4):241-8. PubMed ID: 2566707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 14. General pharmacological properties of dapiprazole, a potential psychotropic agent.
    Lisciani R; Baldini A; Silvestrini B
    Arzneimittelforschung; 1982; 32(6):674-8. PubMed ID: 6126198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic profile of the selective beta 1-adrenoceptor antagonist bisoprolol.
    Harting J; Becker KH; Bergmann R; Bourgois R; Enenkel HJ; Fuchs A; Jonas R; Lettenbaur H; Minck KO; Schelling P
    Arzneimittelforschung; 1986 Feb; 36(2):200-8. PubMed ID: 2870720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
    Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
    Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of pilocarpine and carteolol, a new beta-adrenergic blocking agent on human aqueous humor dynamics (author's transl)].
    Araie M; Takase M
    Nippon Ganka Gakkai Zasshi; 1980 Dec; 84(12):2085-91. PubMed ID: 7246372
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
    Lish PM; Weikel JH; Dungan KW
    J Pharmacol Exp Ther; 1965 Aug; 149(2):161-73. PubMed ID: 4378558
    [No Abstract]   [Full Text] [Related]  

  • 19. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G; Decker N; Schwartz J
    Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.